133 related articles for article (PubMed ID: 2568266)
1. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
Kostrzewa RM; White TG; Zadina JE; Kastin AJ
Eur J Pharmacol; 1989 Apr; 163(1):33-42. PubMed ID: 2568266
[TBL] [Abstract][Full Text] [Related]
2. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
Gong L; Kostrzewa RM; Kalbfleisch JH
Peptides; 1993; 14(6):1159-64. PubMed ID: 7907787
[TBL] [Abstract][Full Text] [Related]
3. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
[TBL] [Abstract][Full Text] [Related]
4. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny.
Saleh MI; Kostrzewa RM
Peptides; 1989; 10(1):35-9. PubMed ID: 2568624
[TBL] [Abstract][Full Text] [Related]
5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
6. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
7. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
Hara C; Kastin AJ
Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
[TBL] [Abstract][Full Text] [Related]
8. Ontogenic homologous supersensitization of dopamine D1 receptors.
Hamdi A; Kostrzewa RM
Eur J Pharmacol; 1991 Oct; 203(1):115-20. PubMed ID: 1839147
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Kostrzewa RM; Saleh MI
Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
[TBL] [Abstract][Full Text] [Related]
10. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
11. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
12. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
Quock RM; Lucas TS; Hartl TJ
Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
[TBL] [Abstract][Full Text] [Related]
14. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Breese GR; Baumeister A; Napier TC; Frye GD; Mueller RA
J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
[TBL] [Abstract][Full Text] [Related]
15. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
Kostrzewa RM; Kastin AJ
Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
[TBL] [Abstract][Full Text] [Related]
16. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
Castellano JM; Batrynchuk J; Dolbeare K; Verma V; Mann A; Skoblenick KJ; Johnson RL; Mishra RK
Peptides; 2007 Oct; 28(10):2009-15. PubMed ID: 17766011
[TBL] [Abstract][Full Text] [Related]
17. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions.
Norman AB; Wyatt LM; Hildebrand JP; Kolmonpunporn M; Moody CA; Lehman MN; Sanberg PR
Pharmacol Biochem Behav; 1990 Dec; 37(4):755-9. PubMed ID: 2128758
[TBL] [Abstract][Full Text] [Related]
19. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
20. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]